PDPN and lung adenocarcinoma: Although podoplanin (D2-40) is essentially not expressed in lung adenocarcinomas (3% of focally positive lung adenocarcinomas) [3,56], it is positive in 60% of lung squamous cell carcinomas [3,57,58,59,60].